Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Phase
N/ASpan
783 weeksSponsor
Bristol-Myers SquibbToyokawa, Aichi
Recruiting
1-1 of 1